News 11 oct 2023 Lonza further extends its ADC manufacturing capabilities in Visp Lonza amplifies ADC production via a robust extension in bioconjugation capacity at its Ibex Dedicate Biopark in Visp, which set to generate 180 ...
News 20 oct 2023 Lonza expands to manufacture Vaxcyte’s pneumococcal conjugate vaccine Lonza and US clinical-stage vaccine innovation company Vaxcyte have announced an expansion in their partnership to establish a global commercial ...
News 04 oct 2023 Atinary Technologies raises USD 5 million to accelerate material and molecular innovation Vaud-based machine learning specialist Atinary Technologies has raised USD 5 million, propelling the start-up towards a new era of material and m...
News 20 oct 2023 Xlife Sciences becomes main shareholder in 4D Lifetec Xlife Sciences, a listed accelerator and investor in innovative healthcare solutions, has made an investment totalling 23.3 million Swiss francs ...
News 19 oct 2023 Researchers reverse prostate cancer therapy resistance Researchers at the Institute of Oncology Research (IOR) have discovered how to reverse prostate cancer therapy resistance. This advancement came ...
News 18 oct 2023 BioArk Monthey’s third building signifies exponential growth in the life sciences sector With two decades under its belt, the BioArk site in Monthey continues to cement its position as a front-runner in life sciences.
News 18 oct 2023 Cimeio collaborating with the University of Pennsylvania The Basel-based start-up Cimeio has been offered an exceptional opportunity for a preclinical research collaboration with the University of Penns...
News 29 sep 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
News 10 oct 2023 MSD commits to Lucerne as a business location MSD Switzerland has its sights set on further growth from its Lucerne location. Since being founded 60 years ago, the pharmaceutical company has ...
News 10 oct 2023 HES-SO Valais-Wallis and Debiopharm partner up to battle cancer HES-SO Valais-Wallis and Debiopharm have entered a partnership to advance targeted cancer therapy research with novel antibody conjugates.
News 10 oct 2023 Nagi Bioscience secures CHF 12.4 million to propel animal-alternative testing Propelling the momentum towards humane, next-gen laboratory solutions, Nagi Bioscience has secured CHF 12.4 million to open doors to new markets ...
Handbook for Investors 08 juin 2023 Handbook for Investors The handbook provides information on the most important aspects of Switzerland as a modern and innovative business and technology location. It co...
Press Release 30 jan 2024 Exports stagnant: Swiss companies adjust their expectations and strategies Swiss SMEs are still expecting minimal export growth in the coming months. This is the finding of the latest survey of Swiss SMEs conducted by Sw...
E-Mail Abmeldung Vielen Dank für Ihre Übermittlung Falls Sie sich für ein neues Thema angemeldet haben, erhalten in Kürze eine E-Mail, in der wir Sie bitten, Ihre Änderung zu bestätigen. Für ...
Fact Sheet 04 mai 2022 Advanced Manufacturing in Switzerland As a production location, Switzerland offers companies optimal conditions to optimize their manufacturing processes through increased efficiency ...
News 10 fév 2020 Valais trains engineers for the future Lonza and HES-SO Valais-Wallis have entered into a training and research partnership with the goal to meet Lonza's need for qualified personnel. ...